Stocks to sell

Shares of Teva Pharmaceuticals (NYSE:TEVA) were up over 9% in late trading on Feb.12. The company posted EPS and revenue that exceeded analysts’ expectations. Source: JHVEPhoto / Shutterstock.com The earnings report made it three quarters in a row that Teva stock has beaten revenue expectations. The bottom line number marked a reversal from the third

On paper, there’s an intriguing bull case for miner Freeport-McMoRan (NYSE:FCX). Freeport-McMoRan stock looks cheap. Copper prices have dipped of late, but have at least one important long-term tailwind. And Freeport has steadily improved its balance sheet in recent years, cutting net debt by over $12 billion between the end of 2015 and the end

[embedded content] Shares of struggling pharmacy retail operator Rite Aid (NYSE:RAD) have sprung back to life in a big way over the past few months, as investors are growing more optimistic on the company’s turnaround plans, but RAD stock still has some hurdles to clear. Source: Michael Gordon / Shutterstock.com Specifically, Rite Aid reported blowout

Global equities are reeling as the coronavirus from China continues to spread globally, killing its first victim in Japan. The outbreak is also forcing China to choose between killing its economy or killing more citizens by sending people back to work too early. Add to that reports the U.S. military is preparing quarantine facilities on

I’m a pretty avid runner and gym goer, and I happen to love Under Armour (NYSE:UA, NYSE:UAA) gear for workouts. However, while I like the attire, UAA stock is another matter — and the company’s latest earnings report underscores that fact very succinctly. Source: Sundry Photography / Shutterstock.com Once the up-and-coming king of the fitness

I’m on record calling the legal marijuana market one of the biggest business booms this century. Despite the extremely turbulent waters that the sector faced last year, I still stand by my bullishness. However, just because the general thesis is strong doesn’t mean every participant will prosper. This brings me to Aurora Cannabis (NYSE:ACB), and

In 2008, Chesapeake Energy (NYSE:CHK) looked like a winning bet. Oil prices hit record highs, natural gas prices spiked to near-record levels, and CHK stock was flying high, punching past $65 that summer. Even as recently as 2014, there was hope that the company’s big bets on natural gas and oil production would pay off

In mid-January InvestorPlace.com contributor Josh Enomoto authored a compelling cautionary note against owning FuelCell Energy (NASDAQ:FCEL) stock. In it, he called it a “penny stock” and “a low-confidence gamble.” He ultimately advised that most folks “should stay far away.” Personally, I don’t have a rule against buying low-priced stocks and I certainly won’t begrudge the good fortune

Nio (NYSE:NIO) has been in the fast-line lately. Since early October, Nio stock has soared from $1.30 to $3.70 – putting the market cap at $3.8 billion. Source: Sundry Photography / Shutterstock.com There are several drivers for this bull move. First of all, the company has been showing positive momentum with its deliveries. In December,

The financial world has focused heavily on Tesla (NASDAQ:TSLA) over the past few weeks. Tesla stock ran up from $400 at the start of the year to as high as $986 per share earlier this month. Source: Shutterstock That sort of move by the shares of a high-profile company has attracted all sorts of attention. Not

AMD (NASDAQ:AMD)  has had a tremendous run as it gained market share on Intel (NASDAQ:INTC)with faster chips. And, of course, that’s led to huge gains by AMD stock over the last few years. Source: Joseph GTK / Shutterstock.com But AMD looks like it has big, potential vulnerabilities when it comes to artificial intelligence and its

Beyond Meat (NASDAQ:BYND) is rolling again, despite being one of 2019’s biggest bubbles. Beyond Meat stock climbed from an initial public offering price of $25 on May 1 to almost $240 by the end of July. By year-end, the company had fallen over two-thirds from its peak. Source: Shutterstock Of course, even after the decline,

Beleaguered oil and gas firm Chesapeake Energy (NYSE:CHK) is again generating headlines for the wrong reasons. Recently, a Reuters report revealed that the daughter of a worker who was tragically killed in an oil-well explosion sued Chesapeake and three other organizations, claiming in part an unsafe work environment. Although it won’t kill CHK stock on

The bull move in Apple (NASDAQ:AAPL) stock has been impressive. Just a year ago, the prospects for the company looked far from promising. The company had fumbled with various products, was lagging in China and its iPhone models seemed lackluster. Source: View Apart / Shutterstock.com But of course, the problems were temporary. While CEO Tim

Talk about a blast from the past. General Electric (NYSE:GE) stock is up over 16% so far this year, thanks in part to a better-than-expected earnings report last week that has some believing there’s new life in the beleaguered company. Source: JPstock/Shutterstock.com Bank of America analyst Andrew Obin raised his price target for GE stock

Aurora Cannabis (NYSE:ACB) stock has not done well in recent months and on Thursday after the market closed, things got even worse. Aurora stock fell 5.6% on the day and plunged further in after-hours trading on news that its CEO, Terry Booth, would step down. Source: Shutterstock The company also announced a “business transformation plan,”

With Nvidia (NASDAQ:NVDA) stock holding steady, is it time to sell? After last year’s epic run, the high-flying chipmaker may be peaking. With Advanced Micro Device’s (NASDAQ:AMD) mixed guidance, investors are starting to scale back their expectations for the other chip names as well. Source: Hairem / Shutterstock.com As I’ve discussed in prior analyses for

Since mid-2016, AMD (NASDAD:AMD) stock has climbed steadily higher. The shares have now advanced around 25 times from their lowest point of the last four years. Source: Hand Robot/Shutterstock.com Surely that incredible stock price appreciation has coincided with the tremendous growth of AMD’s profits over that span, right? Well actually, not so much. The company generates

On its surface, Johnson & Johnson (NYSE:JNJ) is a fine and stable consumer and pharmaceutical healthcare giant, supported by steady demand drivers for health care products and healthy profit margins which have room to keep expanding with scale. All else equal, that slow and steady growth profile should theoretically lead to slow and steady gains

Last year was certainly the year of the IPO, or more accurately, the year of the failed IPO. In 2019 we saw a range of buzzy tech firms fall significantly in the days, weeks and months following their debuts. Ride-hailing service Lyft (NASDAQ:LYFT) is one such company. Source: Roman Tiraspolsky / Shutterstock.com With LYFT stock